Details for New Drug Application (NDA): 014122
✉ Email this page to a colleague
NDA 014122 describes PROTOPAM CHLORIDE, which is a drug marketed by Baxter Hlthcare Corp and Wyeth Ayerst and is included in two NDAs. It is available from one supplier. Additional details are available on the PROTOPAM CHLORIDE profile page.
The generic ingredient in PROTOPAM CHLORIDE is pralidoxime chloride. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pralidoxime chloride profile page.
The generic ingredient in PROTOPAM CHLORIDE is pralidoxime chloride. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pralidoxime chloride profile page.
Summary for 014122
| Tradename: | PROTOPAM CHLORIDE |
| Applicant: | Wyeth Ayerst |
| Ingredient: | pralidoxime chloride |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
